Kimia Biosciences Ltd
₹31.00▼ -1.11 (-3.46%)
KIMIABL·BSE·Healthcare
Market Cap
146.67 Cr
PE Ratio
19.40
Volume
631
Day High - Low
31.47 - 31.00
52W High-Low
43.28 - 23.20
₹31.00▼ -1.11 (-3.46%)
Market Cap146.67 Cr
PE Ratio19.40
Volume631
Day High - Low31.47 - 31.00
52W High-Low43.28 - 23.20
Kimia Biosciences Ltd (KIMIABL): company summary
The company's annual revenue fell 3.4% to ₹115 crore, while annual net profit dropped 22.7% to ₹7 crore.
Kimia Biosciences Ltd (KIMIABL) is a micro-cap Healthcare company valued at ₹147 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Kimia Biosciences Ltd last traded at ₹31, down 3.46% on the day.
- Recent developments
- On 2026-06-30, the company reported a net profit of ₹0 crore for the latest quarter, marking a sharp decline from ₹1 crore in the same period a year earlier. The company's promoter holding remained at 74.94%, with no change in foreign institutional holdings.
- Financial performance
- The company's annual revenue fell 3.4% to ₹115 crore, while annual net profit dropped 22.7% to ₹7 crore. The latest quarter saw revenue decline 12.1% year-on-year to ₹21 crore, and net profit fell 40.0% to ₹0 crore, indicating a significant slowdown in profitability.
- Valuation multiples
- The stock trades at 19.4 times earnings, a discount to the Healthcare median of 32.0, 7.88 times book value.
- Things to watch
- The company's net profit margin narrowed 1.6 percentage points to 6.5%, and its debt to equity ratio stands at 1.96, indicating higher leverage. The stock is 25.8% below its 52-week high, and the latest quarter's net profit dropped to zero, raising concerns about short-term financial performance.
- Where it stands
- Kimia Biosciences Ltd ended the latest quarter with a net profit of ₹0 crore, a sharp decline from ₹1 crore a year earlier. The company's net profit margin and profitability have both deteriorated, with the stock trading 25.8% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.8/10
Poor
Fair Value
Sign in to see
ROE
41.95%
Strong
P/E
19.40x
Fair
Debt / Equity
1.96
High
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
Day₹31.00
₹31.47
52W₹23.20
₹43.28
DocStoX take
Held back by growth (3.3).
DocStoX score
Low confidence3.8
/10
Poor
Quality
Modest
ROE 41.9%
Valuation
Rich
P/E 19.4×
Growth
Slow
Revenue -2.9% 5Y CAGR
Risk
Elevated
D/E 1.96
Momentum
Soft
39% of 52-week range
At a glance
Market Cap
₹147 Cr
52W High / Low
₹43 / ₹23
Dividend Yield
0.00%
Promoter Holding
74.94%
EPS (TTM)
₹1.60
Book Value
₹37.46
Key highlights
- Strong returns on equity (42%)
- Capital works hard — ROCE 23%
- Revenue shrinking 3% a year
- High leverage — debt is 2.0× equity
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Kimia Biosciences Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Kimia Biosciences Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Kimia Biosciences Ltd with peers
Related tools & concepts
Value Kimia Biosciences Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing